Agenda
Items to be discussed | Actions | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Prerelease Content Management Activities:
|
| ||||||||||||||||||||||||||||||||
2 | Discussion of existing Known Issues from the previous Release |
I have checked a sample of the attached file, the issue is the same, the concepts are marked fully defined by virtue of their stated IS_A relationships which was in the past acceptable, editorial policy has subsequently changed and we now require a proximal primitive parent and the addition of attribute and value pairs. These modelling issues are being addressed by the QI project in many cases using template based editing, no changes required at present. Can we close this down then??
| ||||||||||||||||||||||||||||||||
3 | Content Validation Activities in the Current Release cycle:
| |||||||||||||||||||||||||||||||||
4 | Content Team Support availability - Confirm which members of the content team will remain on stand-by until clean database milestone is achieved after release build file QA and post-release assertions are validated. |
| ||||||||||||||||||||||||||||||||
5 | Early visibility of Release Notes | Andrew Atkinson has created the template to update on Confluence: SNOMED CT January 2021 International Edition - SNOMED International Release notes - content team to update with relevant figures for January 2021 content..... ACTION: Maria Braithwaite and Donna Morgan will kindly aim to get them to Andrew Atkinson by 25 November 2020. ACTION: Monica Harry and Paul Amos to review and approve once complete
| ||||||||||||||||||||||||||||||||
6 | Brief run through of the known issues already identified by the content team during the QA batch process, to ensure that technical team are aware of them, and can either resolve them in time for the release, or confirm as known issues. | Any? | ||||||||||||||||||||||||||||||||
7 | Versioning and Change Freeze | |||||||||||||||||||||||||||||||||
8 | Stats Report | |||||||||||||||||||||||||||||||||
9 | Risks |